Medication info
Telmistar 80 mg (Telmisartan)

Telmistar 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
White or almost white, double convex, round tablet
Packaging
30 tablets/box [(10 tablets/PTP) x 3]
Approval status
Active

MFDS item code 201607285 · Approved 2016.12.27 · Insurance code 645906170

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive drugs may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • and clinical evidence of end-organ damage in high-risk diabetes
View approved original text

This medication helps to effectively control blood pressure in patients with essential hypertension. It is also used to reduce the risk of myocardial infarction, stroke, and mortality from cardiovascular diseases in patients with a history of coronary artery disease, peripheral artery disease, strokes, or high-risk diabetes. It is especially suitable for patients who have difficulty using ACE inhibitors. This medicine lowers the risks associated with cardiovascular diseases, improving the overall health status of the patient. Therefore, it is used both for managing hypertension and for reducing cardiovascular disease risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive drugs may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to this medication or its ingredients, pregnant or nursing women, patients with severe liver impairment, hereditary angioedema, and those with certain kidney diseases should not take this medication. Elderly patients, those with high potassium levels, liver impairment, heart valve disease, ischemic heart disease, gastrointestinal diseases, and renal impairment should take precautions while using this medication. During treatment, various side effects such as hypotension, dizziness, cough, abdominal pain, liver dysfunction, angioedema, myalgia, and renal impairment may occur, so if any unusual symptoms arise, a doctor should be consulted immediately. Particular caution is advised if taking potassium supplements or potassium-sparing diuretics due to the potential for increased potassium levels in the blood. This medication may enhance the blood pressure-lowering effects if taken with other antihypertensive agents, so it should be taken according to the doctor's instructions. Patients with reduced kidney function should have regular blood tests to monitor kidney function and electrolyte levels. It is advisable not to take this medication for 24 hours prior to surgery, and caution is needed when driving or operating dangerous machinery due to the risk of dizziness or fainting. In case of overdose, symptoms such as hypotension, heart rhythm abnormalities, dizziness, and acute renal failure may occur, necessitating immediate hospital treatment. The safety and efficacy of this medication in children and adolescents have not been established, so it is not recommended for this population. Store in a place out of the reach of children, ensure it is protected from moisture, and open the packaging just before use.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 122 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • somnolence
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver disorders
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • kidney failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dyspepsia
  • cough
  • abdominal pain
  • appetite loss
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute kidney failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1 to 30 degrees Celsius. Storing it this way ensures the medication's effectiveness is maintained for a longer duration and prevents degradation.

Appearance and packaging

Appearance

White or almost white, double convex, round tablet

Package unit

30 tablets/box [(10 tablets/PTP) x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.